Learn More
Invitrogen™ Nipocalimab Recombinant Monoclonal Antibody

Recombinant Monoclonal Antibody
Brand: Invitrogen™ MA559521
Description
For reconstitution, add sterile, distilled water to achieve a final antibody concentration of 1 mg/mL. Gently shake to solubilize the protein completely. Do not vortex. Reconstituted products should be stored at -80 °.
Nipocalimab works by binding to the neonatal Fc receptor (FcRn), inhibiting its interaction with immunoglobulin G (IgG), thereby reducing the levels of pathogenic IgG antibodies.
Specifications
| Nipocalimab | |
| Recombinant Monoclonal | |
| Unconjugated | |
| JNJ 80202135; M 281 | |
| Protein A | |
| RUO | |
| Human | |
| Antibody | |
| IgG1 κ |
| ELISA, Flow Cytometry, Functional Assay, Surface Plasmon Resonance | |
| 1 mg/mL | |
| 25mM histidine with 0.01% Tween 80, 8% sucrose and no preservative; pH 6.2 | |
| Human | |
| 100 μg | |
| Primary | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.